Radiotherapy quality matters to the trial result.
Aitrium is the all-in-one platform for radiotherapy data collection, analysis, and review. We built it so quality assurance can be standard practice in every trial that needs it.
Review radiotherapy quality alongside the rest of your trial data.




The same tumor, outlined differently. The same prescription, delivered differently. Whole regimens that shift from one patient to the next. Each difference adds noise, and noise can bury a real drug effect, or flatter a false one.
Aitrium brings protocol checks and review records into the trial workflow, giving sponsors a clearer view of radiation planning quality.
Radiotherapy quality is not random.Unmeasured, it is bias in your efficacy data.
Radiotherapy QA should be as routine, and as unremarkable, as the data standards drug sponsors already meet.
CDISC began as a private data standard, built by an industry consortium and adopted by consensus, then ratified into an FDA requirement. Today you cannot get a drug approved without it. We believe radiotherapy standards can follow the same consensus-led path.
Aitrium connects collection, protocol checks and central review so trial teams can track each submission through the same workflow.

Enroll sites and patients in minutes. Automated protocol ingestion generates rich collection schedules, and a typical upload is delivered in under two minutes with validation built in.
Standardization and automated QA scorecards, with a wide range of insights generated before any human review.
Adherence enforced automatically, so deviations are caught before central review. Queue, triage, and routing handled by the protocol.
A reviewer-grade, protocol-informed DICOM workspace where the final read happens.
1. Median 98 seconds start to finish, including user review; median active processing 41 seconds. 54 production submissions across 10 clinical institutions in 6 countries (March to July 2026), measured from platform audit telemetry.